Annual EBITDA:
$337.93M+$32.58M(+10.67%)Summary
- As of today, HAE annual EBITDA is $337.93 million, with the most recent change of +$32.58 million (+10.67%) on March 31, 2025.
- During the last 3 years, HAE annual EBITDA has risen by +$128.94 million (+61.69%).
- HAE annual EBITDA is now at all-time high.
Performance
HAE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$95.53M+$11.64M(+13.87%)Summary
- As of today, HAE quarterly EBITDA is $95.53 million, with the most recent change of +$11.64 million (+13.87%) on September 27, 2025.
- Over the past year, HAE quarterly EBITDA has increased by +$9.83 million (+11.47%).
- HAE quarterly EBITDA is now at all-time high.
Performance
HAE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$350.67M+$9.83M(+2.88%)Summary
- As of today, HAE TTM EBITDA is $350.67 million, with the most recent change of +$9.83 million (+2.88%) on September 27, 2025.
- Over the past year, HAE TTM EBITDA has increased by +$35.17 million (+11.15%).
- HAE TTM EBITDA is now at all-time high.
Performance
HAE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HAE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.7% | +11.5% | +11.2% |
| 3Y3 Years | +61.7% | +36.6% | +48.0% |
| 5Y5 Years | +10.7% | +80.9% | +53.0% |
HAE EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +61.7% | at high | +42.8% | at high | +48.0% |
| 5Y | 5-Year | at high | +89.0% | at high | +367.4% | at high | +112.0% |
| All-Time | All-Time | at high | +996.0% | at high | +1359.7% | at high | +852.9% |
HAE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $95.53M(+13.9%) | $350.67M(+2.9%) |
| Jun 2025 | - | $83.90M(+5.3%) | $340.84M(+3.1%) |
| Mar 2025 | $337.93M(+10.7%) | $79.67M(-13.0%) | $330.46M(+0.3%) |
| Dec 2024 | - | $91.57M(+6.8%) | $329.59M(+4.5%) |
| Sep 2024 | - | $85.71M(+16.6%) | $315.50M(+5.6%) |
| Jun 2024 | - | $73.51M(-6.7%) | $298.70M(-1.0%) |
| Mar 2024 | $305.35M(+17.2%) | - | - |
| Mar 2024 | - | $78.80M(+1.7%) | $301.87M(+2.8%) |
| Dec 2023 | - | $77.48M(+12.4%) | $293.56M(+3.7%) |
| Sep 2023 | - | $68.91M(-10.1%) | $282.97M(-0.4%) |
| Jun 2023 | - | $76.68M(+8.8%) | $284.02M(+9.2%) |
| Mar 2023 | $260.51M(+24.6%) | $70.49M(+5.4%) | $260.00M(+7.0%) |
| Dec 2022 | - | $66.89M(-4.4%) | $243.00M(+2.6%) |
| Sep 2022 | - | $69.95M(+32.8%) | $236.95M(+9.8%) |
| Jun 2022 | - | $52.67M(-1.5%) | $215.74M(+17.6%) |
| Mar 2022 | $209.00M(+16.9%) | $53.49M(-12.1%) | $183.51M(+10.5%) |
| Dec 2021 | - | $60.84M(+24.8%) | $166.01M(+0.4%) |
| Sep 2021 | - | $48.74M(+138.4%) | $165.37M(-2.4%) |
| Jun 2021 | - | $20.44M(-43.2%) | $169.43M(-9.2%) |
| Mar 2021 | $178.81M(-41.4%) | $36.00M(-40.2%) | $186.66M(-11.8%) |
| Dec 2020 | - | $60.19M(+14.0%) | $211.73M(-7.6%) |
| Sep 2020 | - | $52.80M(+40.2%) | $229.17M(-10.8%) |
| Jun 2020 | - | $37.67M(-38.3%) | $256.90M(-15.9%) |
| Mar 2020 | $305.32M(+24.2%) | $61.07M(-21.3%) | $305.31M(-1.2%) |
| Dec 2019 | - | $77.64M(-3.6%) | $309.05M(+5.0%) |
| Sep 2019 | - | $80.53M(-6.5%) | $294.29M(+8.4%) |
| Jun 2019 | - | $86.08M(+32.8%) | $271.55M(+10.2%) |
| Mar 2019 | $245.76M(+27.3%) | $64.80M(+3.1%) | $246.49M(+10.0%) |
| Dec 2018 | - | $62.88M(+8.8%) | $224.16M(+3.6%) |
| Sep 2018 | - | $57.78M(-5.3%) | $216.39M(+2.6%) |
| Jun 2018 | - | $61.02M(+43.7%) | $210.94M(+10.5%) |
| Mar 2018 | $193.03M(+4.3%) | $42.48M(-22.9%) | $190.83M(+2.5%) |
| Dec 2017 | - | $55.10M(+5.3%) | $186.24M(+2.4%) |
| Sep 2017 | - | $52.33M(+27.9%) | $181.81M(+1.8%) |
| Jun 2017 | - | $40.91M(+8.0%) | $178.58M(+5.2%) |
| Mar 2017 | $184.99M(+0.1%) | $37.89M(-25.2%) | $169.81M(+5.5%) |
| Dec 2016 | - | $50.68M(+3.2%) | $160.96M(+3.4%) |
| Sep 2016 | - | $49.10M(+52.7%) | $155.63M(+0.3%) |
| Jun 2016 | - | $32.15M(+10.7%) | $155.11M(-5.2%) |
| Mar 2016 | $184.72M(-7.1%) | $29.03M(-36.0%) | $163.63M(-11.0%) |
| Dec 2015 | - | $45.35M(-6.6%) | $183.84M(-4.2%) |
| Sep 2015 | - | $48.57M(+19.4%) | $191.92M(-0.2%) |
| Jun 2015 | - | $40.68M(-17.4%) | $192.21M(-0.6%) |
| Mar 2015 | $198.81M(-9.3%) | $49.23M(-7.9%) | $193.37M(-1.4%) |
| Dec 2014 | - | $53.44M(+9.4%) | $196.03M(-1.4%) |
| Sep 2014 | - | $48.87M(+16.8%) | $198.77M(-7.9%) |
| Jun 2014 | - | $41.84M(-19.4%) | $215.70M(+3.2%) |
| Mar 2014 | $219.13M(+28.8%) | $51.90M(-7.6%) | $209.08M(+0.8%) |
| Dec 2013 | - | $56.17M(-14.6%) | $207.50M(+3.8%) |
| Sep 2013 | - | $65.80M(+86.8%) | $199.81M(+14.6%) |
| Jun 2013 | - | $35.22M(-30.0%) | $174.32M(+2.5%) |
| Mar 2013 | $170.11M(+18.4%) | $50.31M(+3.8%) | $170.06M(+10.1%) |
| Dec 2012 | - | $48.48M(+20.3%) | $154.42M(+5.9%) |
| Sep 2012 | - | $40.30M(+30.2%) | $145.75M(+5.3%) |
| Jun 2012 | - | $30.96M(-10.7%) | $138.43M(-3.7%) |
| Mar 2012 | $143.70M(-10.9%) | $34.67M(-12.9%) | $143.70M(-4.3%) |
| Dec 2011 | - | $39.81M(+20.7%) | $150.16M(-2.0%) |
| Sep 2011 | - | $32.99M(-9.0%) | $153.21M(-4.4%) |
| Jun 2011 | - | $36.23M(-11.9%) | $160.19M(-1.0%) |
| Mar 2011 | $161.28M(-2.2%) | $41.13M(-4.0%) | $161.77M(-7.1%) |
| Dec 2010 | - | $42.86M(+7.3%) | $174.18M(+2.6%) |
| Sep 2010 | - | $39.96M(+5.7%) | $169.69M(+1.3%) |
| Jun 2010 | - | $37.81M(-29.4%) | $167.50M(+1.5%) |
| Mar 2010 | $164.95M(+24.5%) | $53.54M(+39.5%) | $164.95M(+17.5%) |
| Dec 2009 | - | $38.37M(+1.6%) | $140.34M(+1.3%) |
| Sep 2009 | - | $37.77M(+7.1%) | $138.55M(+3.0%) |
| Jun 2009 | - | $35.27M(+21.9%) | $134.49M(+4.8%) |
| Mar 2009 | $132.54M(+21.5%) | $28.93M(-20.9%) | $128.28M(-2.5%) |
| Dec 2008 | - | $36.59M(+8.5%) | $131.59M(+6.1%) |
| Sep 2008 | - | $33.71M(+16.0%) | $124.02M(+7.6%) |
| Jun 2008 | - | $29.06M(-9.9%) | $115.23M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | $109.05M(+12.1%) | $32.24M(+11.1%) | $109.13M(+4.6%) |
| Dec 2007 | - | $29.02M(+16.4%) | $104.29M(+4.4%) |
| Sep 2007 | - | $24.92M(+8.5%) | $99.94M(+3.4%) |
| Jun 2007 | - | $22.96M(-16.2%) | $96.70M(-0.4%) |
| Mar 2007 | $97.29M(-2.0%) | $27.40M(+11.1%) | $97.13M(-1.5%) |
| Dec 2006 | - | $24.66M(+13.8%) | $98.62M(+1.0%) |
| Sep 2006 | - | $21.68M(-7.3%) | $97.65M(-0.7%) |
| Jun 2006 | - | $23.39M(-19.1%) | $98.30M(-0.4%) |
| Mar 2006 | $99.29M(+6.8%) | $28.89M(+21.9%) | $98.74M(+6.1%) |
| Dec 2005 | - | $23.69M(+6.1%) | $93.07M(-0.5%) |
| Sep 2005 | - | $22.33M(-6.3%) | $93.58M(-0.0%) |
| Jun 2005 | - | $23.83M(+2.6%) | $93.59M(+1.9%) |
| Mar 2005 | $92.97M(+16.0%) | $23.22M(-4.0%) | $91.89M(+1.0%) |
| Dec 2004 | - | $24.20M(+8.3%) | $90.97M(+2.5%) |
| Sep 2004 | - | $22.35M(+1.0%) | $88.74M(+3.0%) |
| Jun 2004 | - | $22.12M(-0.8%) | $86.14M(+8.0%) |
| Mar 2004 | $80.13M(+21.6%) | $22.31M(+1.6%) | $79.79M(+14.2%) |
| Dec 2003 | - | $21.96M(+11.2%) | $69.89M(+3.3%) |
| Sep 2003 | - | $19.75M(+25.2%) | $67.66M(+4.2%) |
| Jun 2003 | - | $15.77M(+27.2%) | $64.92M(-1.5%) |
| Mar 2003 | $65.91M(-8.5%) | $12.40M(-37.2%) | $65.91M(-12.8%) |
| Dec 2002 | - | $19.74M(+16.0%) | $75.61M(+21.1%) |
| Sep 2002 | - | $17.01M(+1.5%) | $62.42M(-8.2%) |
| Jun 2002 | - | $16.76M(-24.2%) | $68.02M(+2.1%) |
| Mar 2002 | $72.06M(+17.9%) | $22.11M(+237.8%) | $66.63M(+10.8%) |
| Dec 2001 | - | $6.54M(-71.0%) | $60.11M(-14.8%) |
| Sep 2001 | - | $22.60M(+47.1%) | $70.57M(+13.3%) |
| Jun 2001 | - | $15.37M(-1.4%) | $62.26M(+1.7%) |
| Mar 2001 | $61.14M(+4.4%) | $15.59M(-8.3%) | $61.24M(+5.6%) |
| Dec 2000 | - | $17.00M(+18.9%) | $57.98M(+5.0%) |
| Sep 2000 | - | $14.29M(-0.4%) | $55.21M(-3.0%) |
| Jun 2000 | - | $14.35M(+16.4%) | $56.90M(-2.5%) |
| Mar 2000 | $58.54M(-4.5%) | $12.34M(-13.3%) | $58.36M(-8.1%) |
| Dec 1999 | - | $14.22M(-11.0%) | $63.49M(-0.1%) |
| Sep 1999 | - | $15.99M(+1.1%) | $63.54M(+0.8%) |
| Jun 1999 | - | $15.81M(-9.5%) | $63.01M(+2.8%) |
| Mar 1999 | $61.30M(+14.0%) | $17.46M(+22.3%) | $61.30M(+19.6%) |
| Dec 1998 | - | $14.28M(-7.6%) | $51.24M(-0.6%) |
| Sep 1998 | - | $15.46M(+9.7%) | $51.56M(+0.7%) |
| Jun 1998 | - | $14.10M(+90.5%) | $51.20M(-1.5%) |
| Mar 1998 | $53.77M(-11.4%) | $7.40M(-49.3%) | $52.00M(-24.4%) |
| Dec 1997 | - | $14.60M(-3.3%) | $68.80M(+0.1%) |
| Sep 1997 | - | $15.10M(+1.3%) | $68.70M(-2.1%) |
| Jun 1997 | - | $14.90M(-38.4%) | $70.20M(-3.4%) |
| Mar 1997 | $60.72M(-10.1%) | $24.20M(+66.9%) | $72.70M(+16.9%) |
| Dec 1996 | - | $14.50M(-12.7%) | $62.20M(-5.5%) |
| Sep 1996 | - | $16.60M(-4.6%) | $65.80M(-1.9%) |
| Jun 1996 | - | $17.40M(+27.0%) | $67.10M(-0.4%) |
| Mar 1996 | $67.51M(+2.2%) | $13.70M(-24.3%) | $67.40M(-3.2%) |
| Dec 1995 | - | $18.10M(+1.1%) | $69.60M(+2.1%) |
| Sep 1995 | - | $17.90M(+1.1%) | $68.20M(+0.7%) |
| Jun 1995 | - | $17.70M(+11.3%) | $67.70M(+2.1%) |
| Mar 1995 | $66.09M(+5.6%) | $15.90M(-4.8%) | $66.30M(-0.5%) |
| Dec 1994 | - | $16.70M(-4.0%) | $66.60M(+0.3%) |
| Sep 1994 | - | $17.40M(+6.7%) | $66.40M(+2.0%) |
| Jun 1994 | - | $16.30M(+0.6%) | $65.10M(+4.0%) |
| Mar 1994 | $62.56M(+24.3%) | $16.20M(-1.8%) | $62.60M(+4.7%) |
| Dec 1993 | - | $16.50M(+2.5%) | $59.80M(+5.1%) |
| Sep 1993 | - | $16.10M(+16.7%) | $56.90M(+6.8%) |
| Jun 1993 | - | $13.80M(+3.0%) | $53.30M(+5.5%) |
| Mar 1993 | $50.34M(+36.6%) | $13.40M(-1.5%) | $50.50M(+6.1%) |
| Dec 1992 | - | $13.60M(+8.8%) | $47.60M(+9.2%) |
| Sep 1992 | - | $12.50M(+13.6%) | $43.60M(+9.0%) |
| Jun 1992 | - | $11.00M(+4.8%) | $40.00M(+8.7%) |
| Mar 1992 | $36.85M(+19.5%) | $10.50M(+9.4%) | $36.80M(-44.0%) |
| Dec 1991 | - | $9.60M(+7.9%) | $65.70M(-31.1%) |
| Sep 1991 | - | $8.90M(+14.1%) | $95.40M(-24.2%) |
| Jun 1991 | - | $7.80M(-80.2%) | $125.80M(-20.0%) |
| Mar 1991 | $30.83M | $39.40M(+0.3%) | $157.30M(+33.4%) |
| Dec 1990 | - | $39.30M(0.0%) | $117.90M(+50.0%) |
| Sep 1990 | - | $39.30M(0.0%) | $78.60M(+100.0%) |
| Jun 1990 | - | $39.30M | $39.30M |
FAQ
- What is Haemonetics Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Haemonetics Corporation?
- What is Haemonetics Corporation annual EBITDA year-on-year change?
- What is Haemonetics Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Haemonetics Corporation?
- What is Haemonetics Corporation quarterly EBITDA year-on-year change?
- What is Haemonetics Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Haemonetics Corporation?
- What is Haemonetics Corporation TTM EBITDA year-on-year change?
What is Haemonetics Corporation annual EBITDA?
The current annual EBITDA of HAE is $337.93M
What is the all-time high annual EBITDA for Haemonetics Corporation?
Haemonetics Corporation all-time high annual EBITDA is $337.93M
What is Haemonetics Corporation annual EBITDA year-on-year change?
Over the past year, HAE annual EBITDA has changed by +$32.58M (+10.67%)
What is Haemonetics Corporation quarterly EBITDA?
The current quarterly EBITDA of HAE is $95.53M
What is the all-time high quarterly EBITDA for Haemonetics Corporation?
Haemonetics Corporation all-time high quarterly EBITDA is $95.53M
What is Haemonetics Corporation quarterly EBITDA year-on-year change?
Over the past year, HAE quarterly EBITDA has changed by +$9.83M (+11.47%)
What is Haemonetics Corporation TTM EBITDA?
The current TTM EBITDA of HAE is $350.67M
What is the all-time high TTM EBITDA for Haemonetics Corporation?
Haemonetics Corporation all-time high TTM EBITDA is $350.67M
What is Haemonetics Corporation TTM EBITDA year-on-year change?
Over the past year, HAE TTM EBITDA has changed by +$35.17M (+11.15%)